Stock Markets April 14, 2026 01:42 AM

Cicor Posts 22.6% Q1 Revenue Lift on M&A; Organic Sales Slip 6%

Company cites supply chain issues, component shortages and FX headwinds as drivers of organic decline while Aerospace & Defence demand supports orders

By Sofia Navarro CICN
Cicor Posts 22.6% Q1 Revenue Lift on M&A; Organic Sales Slip 6%
CICN

Switzerland-based electronics solutions firm Cicor reported first-quarter revenue of CHF 160.7 million, a 22.6% increase year-over-year driven largely by acquisitions. Organic sales fell 6%, a decline the company linked to supply chain constraints, component shortages and adverse foreign exchange movements. Robust order intake from the Aerospace & Defence sector supported the quarter, and management reiterated 2026 guidance for group sales of CHF 700 million to CHF 750 million and adjusted EBITDA of CHF 70 million to CHF 80 million. Cicor expects organic growth to resume in 2026, with the second half of the year slated to contribute most of that recovery.

Key Points

  • Reported first-quarter sales were CHF 160.7 million, up 22.6% year-over-year, primarily due to acquisitions.
  • Organic sales declined 6%, driven by supply chain constraints, component shortages and adverse foreign exchange impacts.
  • Strong order intake was recorded, led by demand from the Aerospace & Defence market; full-year 2026 guidance reaffirmed for CHF 700 million - CHF 750 million in sales and CHF 70 million - CHF 80 million in adjusted EBITDA.

Cicor, a Switzerland-based electronics solutions provider, reported first-quarter sales of CHF 160.7 million, representing a 22.6% increase compared with the same period a year earlier. The company said the rise in reported sales was driven primarily by recent mergers and acquisitions.

Despite the headline increase, Cicor disclosed that organic sales contracted by 6% during the quarter. Management attributed the organic decline to a combination of supply chain constraints, shortages of components and negative effects from foreign exchange rates. These factors, the company said, were the principal forces behind the reduction in underlying revenue.

On the demand side, Cicor reported solid order intake, with the Aerospace & Defence market named as a key source of demand during the quarter. The company indicated that this market helped underpin new orders even as organic revenue trailed previous periods.


Guidance and outlook

Cicor confirmed its full-year 2026 guidance. The group reaffirmed expected sales in a range of CHF 700 million to CHF 750 million. For adjusted EBITDA, management reiterated a forecast between CHF 70 million and CHF 80 million for the year.

Looking beyond the current period, Cicor anticipates a return to organic growth in 2026. The company specified that most of the expected organic recovery is projected to materialize in the second half of 2026.


What this means

  • The reported top-line increase reflects the impact of acquisitive activity rather than an uptick in organic demand.
  • Operational pressures - namely supply chain constraints and component shortages - along with currency headwinds were cited as the chief reasons for the organic sales decline.
  • Order momentum from the Aerospace & Defence sector provided offsetting support to bookings during the quarter.

Cicor's confirmation of its 2026 financial targets and its expectation that organic growth will resume next year give the company a clear forward-looking framework, even as near-term headwinds continue to affect comparables and underlying sales performance.

Risks

  • Ongoing supply chain constraints and component shortages could continue to depress organic revenue - this risk directly impacts manufacturing and electronics sectors.
  • Negative foreign exchange movements may further weigh on reported organic sales and profitability - this risk affects companies with international operations and cross-border sales.
  • Dependence on a recovery in organic growth in 2026 creates timing uncertainty - if the expected second-half pickup does not materialize, guidance and underlying performance could be challenged.

More from Stock Markets

Australian Shares Slip as Healthcare, Financials and Gold Weigh on Index Apr 29, 2026 Fuchs posts Q1 results above forecasts, raises sales outlook for 2026 Apr 29, 2026 Huhtamaki Tops Q1 Expectations but Flags Rising Polymer Costs as Margin Risk Apr 29, 2026 Kambi Holds FY26 EBITA Target Despite €4m Colombia Tax Hit Apr 29, 2026 Pernod Ricard Calls Off Merger Negotiations With Brown-Forman Apr 29, 2026